
Molly Henderson, the Chief Financial Officer and Executive Vice President of Advaxis, has announced her resignation that will take effect …

Advaxis, a US biotech in cancer immunotherapy development, has announced that its lead immunotherapy product axalimogene filolisbac (AXAL) has hit …

AZ’s MedImmune has entered into a clinical trial collaboration with US biotech firm Advaxis to help develop new cancer immunotherapies. …

Hospira has made significant progress in restoring quality compliance at its facilities in Rocky Mount and Austin, which were the …